VASA2025-10-012026-03-31VASA2026-03-31VASA2025-03-31VASA2025-04-012026-03-31VASA2025-10-012026-03-31in-capmkt:OtherExpenses1MemberVASA2025-04-012026-03-31in-capmkt:OtherExpenses1MemberVASA2026-03-31OtherLongTermLiabilitiesDomain1VASA2026-03-31OtherCurrentAssetsDomain1VASA2025-10-012026-03-31AuditorDomain1VASA2025-10-012026-03-31in-capmkt:AuditedMemberVASA2026-03-31in-capmkt:AuditedMemberVASA2025-10-012026-03-31in-capmkt:AdjustedMemberVASA2026-03-31in-capmkt:AdjustedMemberVASA2025-10-012026-03-31AuditQualification1iso4217:INRiso4217:INRxbrli:shares000000VASANOTLISTEDINE068Z01016VASA RETAIL AND OVERSEAS LTDSMEEquity2025-04-012026-03-312026-05-302026-05-23INRLakhsHalf YearlyYearlySingle segmentTRADING OF STATIONERIES AND RAW MATERIALS2026-05-3013:00:002026-05-3017:10:00trueCash Flow IndirectStatement on impact of audit qualificationfalsefalseNANAfalsefalsefalsefalseNA2025-10-012026-03-31AuditedStandalone0000009000000437000527000-5270000-5270000-527000000-527000000-527000-52700059926000100.140.142025-04-012026-03-31AuditedStandalone00000018000000687000867000-8670000-8670000-867000000-867000000-867000-8670005992600010-2393100000.140.14Other Expenses437000Other Expenses68700059926000-2393100000-179384000010820000000108200000117715000044420004442000732500012948200058298000000019500001950000736900027894000200001752300053150005810300058298000In view of potential impact of earlier set back off <BR> Covid- 19 pandemic and nationwide lockdown on Stationery business, the outcome cannot be presently ascertained and other matters mentioned in the report. <BR> NA0Other Current assets53150000000000000000002440000244000244000-62300000000-62300000-62300000000000000000000000000000007170009400000006230000062300000020002000AuditedQualified opinionAmit Ray & Companytrue2028-03-3100-867000-867000-867000-867000-0.14-0.1458298000582980005829800058298000-179384000-179384000We draw attention to Note 3 & 4 of the Statement, regarding the expiry of license agreement between Oxford Limited (Oxford) and the Company (Vasa) due to permanent discontinuance of business operations and activities by Oxford due to Covid- 19 impact. almost all stock (except few stocks remain pending) of licensed products has to be disposed of by the Company. <br></br> <br></br> Pending impairment review by the company of all assets and liabilities as at March 31, 2026, No provision in the books of accounts has been made by the company. In the absence of assessment of impairment of the company, we are unable to comment on the recoverable and payable amount with regard to said terms and consequential impact , if any, on the statement. <br></br> Qualified opinionRepetitiveIn view of potential impact of earlier set back off <br></br> Covid- 19 pandemic and nationwide lockdown on Stationery business, the outcome cannot be presently ascertained and other matters mentioned in the report. <br></br> In view of potential impact of earlier set back off <br></br> Covid- 19 pandemic and nationwide lockdown on Stationery business, the outcome cannot be presently ascertained and other matters mentioned in the report. <br></br> In view of potential impact of earlier set back off <br></br> Covid- 19 pandemic and nationwide lockdown on Stationery business, the outcome cannot be presently ascertained and other matters mentioned in the report. <br></br> We are unable to comment on and quantify the potential impact of the expiry of the Oxford License Agreement and Covid-19 lockdown on stationery terms and consequential impact, if any, on Statement.Hardik Bhupendra VasaSujay Sudhakar WaikulMahiesh Sankalchand JaainAmit Ray & CompanyMumbai2026-05-30